Kandace Gollomp, MD
Appointments and Referrals: 1-800-TRY-CHOP (1-800-879-2467)
Skip to content
Appointments and Referrals: 1-800-TRY-CHOP (1-800-879-2467)
MD - University of Pennsylvania School of Medicine, Philadelphia, PA
General Pediatrics - Children’s Hospital of Philadelphia, Philadelphia, PA
Pediatric Hematology/Oncology - Children’s Hospital of Philadelphia, Philadelphia, PA
Pediatric Hematology-Oncology – American Board of PediatricsPediatrics – American Board of Pediatrics
Instructor of Pediatric Hematology, Perelman School of Medicine at the University of Pennsylvania
Gollomp K, Poncz M. Gp1ba-Cre or Pf4-Cre: pick your poison. Blood. 2019;133(4):287-288.
Gollomp K, Kim M, Johnston I, Hayes V, Welsh JD, Arepally GW, Kahn ML, Lambert MP, Cuker A, Cines DB, Rauova L, Kowalska AM, Poncz M. Neutrophil accumulation and NET release contribute to thrombosis in HIT. JCI Insight 2018;3(18).pii:99446 [PMID30232279]
Gollomp K, Friedman D, Poncz M. Platelets can soak it up and then spit it out: Lessons for a novel therapy in TTP and beyond. Athero Thromb Vasc Biol. 2018;38(11):2544-2545. [PMID30354233]
Greineder CF, Johnston I, Villa C, Gollomp K, Esmon CT, Cines DB , Poncz M, Muzykantov VR. ICAM-1-targeted thrombomodulin mitigates tissue-factor driven inflammatory thrombosis in a human endothelialized microfluidic model. Blood Adv. 2017
Gollomp K, Lambert MP, Poncz M. Current status of blood 'pharming': megakaryoctye transfusions as a source of platelets. Curr Opin Hematol. Nov 2017
Bdeir K, Gollomp K, Stasiak M, Mei J, Papiewska-Pajak I, Zhao G, Worthen GS, Cines DB, Poncz M, Kowalska MA. Platelet-specific Chemokines Contribute to the Pathogenesis of Acute Lung Injury. Am J Respir Cell Mol Biol. 2016 Oct 18.
Gollomp K, Rankin SC, White C, Mattei P, Harris MC, Kilpatrick LE, Sheffler-Collins S, McGowan KL,Shah SS. Broad-range bacterial polymerase chain reaction in the microbiologic diagnosis of complicated pneumonia. J Hosp Med. 2011 Oct 12.
Iacovelli J, Zhao C, Wolkow N, Veldman P, Gollomp K, Ojha P, Lukinova N, King A, Feiner L, Esumi N,Zack DJ, Pierce EA, Vollrath D, Dunaief JL. Generation of Cre transgenic mice with postnatal RPEspecificocular expression. Invest Ophthalmol Vis Sci. Mar 2011
M.A. Kessler, M. Yang, K.L Gollomp, H. Jin, L. Iacovitti. The Human Tyrosine Hydroxylase Gene Promoter.Molecular Brain Research. 2003, 112:8-23.
Gollomp K, Lambert MP. The treatment of immune thrombocytopenia. In: Despotovic JM editor. Immune Hematology: Diagnosis and Management of Autoimmune Cytopenias. Springer; Forthcoming 2018.
Sarkar A, Arepally GW, Cines DB, Kowalska AM, Rauova L, Poncz M, Gollomp K. A heparin-induced thrombocytopenia (HIT)-like monoclonal antibody KKO has therapeutic potential in a murine endotoxemia model [abstract]. In: Proceedings of the 60th annual meeting of the American Society of Hematology; 2018 Dec 1-4; San Diego, CA.
Gollomp K, Johnston I, Kim M, Zhai L, Zhao G, Kowalska AM, Poncz M. Platelet Factor 4 (PF4)-Mediated Neutrophil Extracellular Trap Compaction Limits Endothelial Injury and Promotes Survival Following Lipopolysaccharide Challenge. Presented at The American Society of Hematology annual meeting, 2017 December 9-12; Atlanta, GA.
Gollomp K, Hayes V, Johnston I, Kim M, Zhao G, Rauova L, MD, Poncz M. Inhibition of Neutrophil Extracellular Trap Release through the Disruption of PAD4 Leads to Decreased Neutrophil and Platelet Accumulation at Sites of Venular Vascular Injury in a Murine Model of Heparin-Induced Thrombocytopenia. Presented at The American Society of Hematology annual meeting, 2017 December 9-12; Atlanta, GA
Gollomp K, Hayes V, Kim M, Johnston I, Zhao G, Raouva L, Poncz M. Neutrophils and released neutrophil extracellular traps(NETs) contribute to the prothrombotic state in HIT. Presented at The International Society on Thrombosis and Haemostasis International Congress, 2017 July 8-13; Berlin, Germany.
Gollomp K, Johnston I, Kim M, Zhai L, Zhao G, Kowalska AM, Poncz M. PF4 binds and stabilizes neutrophil extracellular traps: implications in sepsis. Presented at The International Society on Thrombosis and Haemostasis International Congress, 2017 July 8-13; Berlin, Germany.
Gollomp K, Johnston I, Rauova L, Cines DB, Kowalska AM, Poncz M. A special role for neutrophil extracellular traps (NETs) and neutrophils in the prothrombotic nature of heparin-induced thrombocytopenia. Presented at The American Society of Hematology annual meeting, 2016 December 3-6; San Diego CA.
Gollomp K, Johnston I, Fatoumata D, Zhao G, Krishnaswamy S, Kowalska AM, Poncz M, Platelet Factor 4 and HIT Antibody Interactions with NETs: A Potential Role in the Prothrombotic Nature of Heparin-induced Thrombocytopenia. Presented at The International Platelet Symposium, 2016 September 16-20; Wellesley, MA.
Gollomp K, Johnston I, Fatoumata D, Zhao G, Krishnaswamy S, Poncz M, Kowalska AM. The NET Effect: Platelet Factor 4 and DNA-Histone Interactions in Sepsis. Presented at The American Society of Hematology annual meeting, 2015 December 5-8; Orlando, FL
Gollomp K, Arulselvan A, Tanzer M, Shibutani S, Lambert MP. Honing in on the Range: Using the Electronic Medical Record to Establish Normal Reference Ranges for Pediatric Coagulation Testing. Presented at The American Society of Hematology annual meeting, 2015 December 5-8; Orlando, FL
Gollomp K. Invited speaker, Philadelphia Hemostasis Education Workshop. Cross-connections between inflammation and thrombosis. Philadelphia, PA, 2019.
Gollomp K. Invited Speaker, Sysmex Educational Symposium. The use of expanded parameters in the diagnosis of management of pediatric hematology. Philadelphia, PA
Gollomp K. Invited Speaker, Society for the Advancement of Blood Management (SABM), Annual meeting. 2017
2016-present, American Heart Association
2014-present, Hemostasis and Thrombosis Research Society
2014-present, American Society of Hematology
The Patient Experience Rating is an average of all responses to the care provider related questions shown above from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.
Responses are measured on a scale of 1 to 5 with 5 being the best score.
We are committed to true transparency. However, to ensure the comments are fair and correctly attributed, we review each one before posting to the website. We exclude entire comments that disclose patient's protected health information, are off-topic, or include other confidential or inappropriate content. Comments will appear on provider bios only if providers have a minimum number of comments.
Comments are shared internally for education purposes to ensure that we are doing our very best for the patients and families for whom we are privileged to care.
The comments are submitted by patients and families and reflect their views and opinions. The comments are not endorsed by and do not reflect the views of Children’s Hospital of Philadelphia.